Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

UPDATE 2-Linde targets hydrogen investments as raises 2020 growth outlook

Published 06/11/2020, 04:52 am
Updated 06/11/2020, 04:54 am
© Reuters.
DE40
-
AIRP
-
NG
-
SX4P
-

* Beats third-quarter earnings forecast

* Raises full-year guidance

* Tops the European chemicals sector index (Adds details from the conference call, updates share performance)

By Bartosz Dabrowski

Nov 5 (Reuters) - Linde LIN.N is considering targeted investments in hydrogen, the U.S.-German company said on Thursday as it raised its full-year earnings forecast after increased industrial gas volumes and higher pricing led to a better-than-expected third quarter.

Hydrogen use is expected to rise as companies such as auto and truckmakers hunt for cleaner fuels amid efforts to reduce greenhouse gas emissions.

Production of hydrogen, which accounts for 7% of sales at the world's largest industrial gases group, could represent a $380 billion opportunity globally by 2040, analysts at Berenberg said in a note last month.

Chief Executive Steve Angel said during a results call that Linde planned to invest in hydrogen in places where it already has a clear presence, including countries and regions which have rich natural gas resources, such as the United States, Russia, northern Africa, Canada, and Australia.

The company raised its full-year guidance as it expressed confidence it its resilience in the face of "significant uncertainty" cased by the COVID-19 pandemic.

"Regardless of the underlying economy, I have confidence in our business model and high-performance culture to continue growing earnings and cash flow for years to come," Angel said.

Linde expects adjusted earnings per share to grow by 10% in 2020, compared to a previous 4% to 6% target. This is close to its initial guidance of 10-13% growth, which Linde cut in May at the height of the coronavirus crisis.

The group reported third-quarter adjusted EPS of $2.15, above the $1.97 expected on average by analysts in a Refinitiv poll, and above Linde's guidance of $1.90 to $1.95. growth sectors were healthcare and electronics, with sales up 5% and 4%, respectively, due to higher medical oxygen volumes, mainly in Latin America, and a rise in memory and hardware demand, primarily from China and South Korea.

France-based Air Liquide AIRP.PA , Linde's biggest competitor, said last month its third-quarter sales fell 8.7%. in Linde closed up 5.7%, outperforming Germany's DAX and topping the European chemicals sector index. .SX4P

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.